Avantor, Inc. (NYSE:AVTR) Shares Acquired by Loomis Sayles & Co. L P

Loomis Sayles & Co. L P increased its position in shares of Avantor, Inc. (NYSE:AVTR) by 1.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 749,713 shares of the company’s stock after purchasing an additional 10,564 shares during the period. Loomis Sayles & Co. L P owned 0.11% of Avantor worth $19,395,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the business. Quadrature Capital Ltd raised its holdings in Avantor by 45.3% during the first quarter. Quadrature Capital Ltd now owns 18,265 shares of the company’s stock worth $467,000 after purchasing an additional 5,695 shares in the last quarter. Kennedy Capital Management LLC lifted its position in Avantor by 50.9% in the first quarter. Kennedy Capital Management LLC now owns 79,483 shares of the company’s stock valued at $2,032,000 after acquiring an additional 26,814 shares during the last quarter. California State Teachers Retirement System lifted its position in Avantor by 0.5% in the first quarter. California State Teachers Retirement System now owns 1,067,938 shares of the company’s stock valued at $27,307,000 after acquiring an additional 5,230 shares during the last quarter. Tidal Investments LLC boosted its stake in Avantor by 19.6% in the first quarter. Tidal Investments LLC now owns 14,654 shares of the company’s stock valued at $375,000 after acquiring an additional 2,399 shares in the last quarter. Finally, Comerica Bank grew its holdings in shares of Avantor by 7.6% during the first quarter. Comerica Bank now owns 914,951 shares of the company’s stock worth $23,395,000 after purchasing an additional 64,450 shares during the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on AVTR. UBS Group reduced their target price on Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a report on Tuesday, October 8th. Wells Fargo & Company reduced their price objective on Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research note on Monday, October 28th. Royal Bank of Canada restated an “outperform” rating and set a $34.00 target price on shares of Avantor in a research report on Thursday, September 26th. Barclays reduced their price target on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research report on Friday, October 25th. Finally, Robert W. Baird lowered their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research report on Monday, October 28th. Three investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $27.57.

Avantor Price Performance

Shares of NYSE AVTR opened at $21.01 on Wednesday. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.06 and a current ratio of 1.54. Avantor, Inc. has a one year low of $19.59 and a one year high of $28.00. The firm has a market capitalization of $14.30 billion, a P/E ratio of 45.67, a PEG ratio of 2.52 and a beta of 1.35. The company’s fifty day moving average is $23.65 and its two-hundred day moving average is $23.79.

Insider Activity at Avantor

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of the business’s stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the sale, the chief accounting officer now directly owns 29,544 shares in the company, valued at approximately $740,372.64. The trade was a 10.66 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.30% of the company’s stock.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.